Company / Total Assets
AbbVie Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$134.0B
FY2025
5-year range
$134.0B / $146.5B
FY2021-FY2025
Trend
-0.9%
vs FY2024
Sector context
#4 of 216
Health Care
What the data says
Among 216 Health Care companies, AbbVie is in the top 2% for total assets. Total Assets has fluctuated over the past 10 years, ranging from $59.4B in FY2018 to $150.6B in FY2020.
Based on SEC 10-K filings.
$134.0B in FY2025 with a 5-year CAGR of -2.3%. Top quartile in the Health Care sector.
Remained stable around $134.0B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- -2.3%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 216This company $134.0B Sector average $7.4B
▼
+1698.5% above sector average
Key checks
Key Insights
- 5-year CAGR of -2.3%, indicating a declining trend.
- In FY2025, total assets decreased 0.9% year-over-year.
- Ranks #4 out of 216 companies in the Health Care sector.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $134.0B | -0.9% |
| FY2024 | $135.2B | +0.3% |
| FY2023 | $134.7B | -2.9% |
| FY2022 | $138.8B | -5.3% |
| FY2021 | $146.5B | -2.7% |
| FY2020 | $150.6B | +69.0% |
| FY2019 | $89.1B | +50.1% |
| FY2018 | $59.4B | -16.2% |
| FY2017 | $70.8B | +7.1% |
| FY2016 | $66.1B | +24.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026